CLDN2 and osteosarcoma: The complex and context-dependent action of the Claudin-2/Afadin axis is reinforced by a recent study that describes the reactivation of ERK signaling pathway via the down-regulation of Afadin by Claudin-2, which decreases the migratory potential of osteosarcoma (OS) cells (Zhang et al. 2018).